D
Denizar Vianna Araújo
Researcher at Rio de Janeiro State University
Publications - 71
Citations - 1120
Denizar Vianna Araújo is an academic researcher from Rio de Janeiro State University. The author has contributed to research in topics: Cost effectiveness & Public health. The author has an hindex of 16, co-authored 70 publications receiving 968 citations. Previous affiliations of Denizar Vianna Araújo include Federal University of São Paulo & National Institute of Standards and Technology.
Papers
More filters
Journal ArticleDOI
The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
Luciana Bahia,Denizar Vianna Araújo,Beatriz D'Agord Schaan,Sergio Atala Dib,Carlos Antonio Negrato,Marluce P.S. Leão,Alberto Ramos,Adriana Costa e Forti,Marília B. Gomes,Maria Cristina Foss,Rosane Aparecida Monteiro,Daniela Saes Sartorelli,Laércio Joel Franco +12 more
TL;DR: Costs increased along with duration of disease, level of care and presence of chronic complications, which suggested a need to reallocate health resources focusing on primary prevention of diabetes and its complications.
Journal ArticleDOI
The costs of overweight and obesity-related diseases in the Brazilian public health system: cross-sectional study
Luciana Bahia,Evandro Silva Freire Coutinho,Laura Augusta Barufaldi,Gabriela de Azevedo Abreu,Thainá Alves Malhão,Camila Pepe Ribeiro de Souza,Denizar Vianna Araújo +6 more
TL;DR: The results confirm that overweight and obesity carry a great economic burden for Brazilian health system and for the society.
Journal ArticleDOI
Custo da insuficiência cardíaca no Sistema Único de Saúde
Denizar Vianna Araújo,Leandro Reis Tavares,Renata Veríssimo,Marcos Bosi Ferraz,Evandro Tinoco Mesquita +4 more
TL;DR: In this article, the authors proposed a dimensioning of the socioeconomic impact and epidemiology of heart failure in Unified Health System - Sistema Unico de Saude (SUS) from 65 years of age.
Journal ArticleDOI
Cost of osteoporotic hip fracture in the Brazilian private health care system
TL;DR: The costs of treating osteoporotic hip fracture are substantial in Brazilian private health care system and this study highlights the savings to health plan companies if an osteoporsic hip fracture can be avoided.
Journal ArticleDOI
Estimating the cost-effectiveness of pneumococcal conjugate vaccination in Brazil
Glaucia Vespa,Dagna Constenla,Camila Pepe,Marco Aurélio Palazzi Sáfadi,Eitan Naaman Berezin,José Cássio de Moraes,Carlos Alberto Herrerias de Campos,Denizar Vianna Araújo,Ana Lucia Andrade +8 more
TL;DR: At the current vaccine price, conjugate vaccination could be a cost-effective investment compared to other options to control childhood diseases and whether vaccination at the current price is affordable to Brazil is required.